Concerns Regarding Study Prioritization and Statistical Power in Evaluating Oral Versus Intravenous Therapy
Clinical Infectious Diseases · 07.10.2026 · 83 (3) · e667-e668
DOI: 10.1093/cid/ciag204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 21.03.2026. Verfasst von Dawd S Siraj und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of Wisconsin, Madison, Madison, Wisconsin, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Infectious Diseases, University of Wisconsin, Madison, Madison, Wisconsin, USA.
- Departmento of Medicine, Office of Biostatistics/Epidemiology, University of Wisconsin, Madison, Madison, Wisconsin, USA.
ORCID-Profile: Dawd S Siraj
Zitieren
APA
Siraj, D. S., & Hollnagel, F. (2026). Concerns Regarding Study Prioritization and Statistical Power in Evaluating Oral Versus Intravenous Therapy. Clinical Infectious Diseases, 83(3), e667-e668. https://doi.org/10.1093/cid/ciag204
Vancouver
Siraj DS, Hollnagel F. Concerns Regarding Study Prioritization and Statistical Power in Evaluating Oral Versus Intravenous Therapy. Clinical Infectious Diseases. 2026;83(3):e667-e668. doi:10.1093/cid/ciag204
BibTeX
@article{Siraj2026,
author = {Siraj, Dawd S and Hollnagel, Fauzia},
title = {Concerns Regarding Study Prioritization and Statistical Power in Evaluating Oral Versus Intravenous Therapy},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {83},
number = {3},
pages = {e667--e668},
doi = {10.1093/cid/ciag204}
}
EUVIMED